Ποια είναι η τιμή για Hunan Er-Kang Pharmaceutical Co., Ltd (300267)

Η τιμή για Hunan Er-Kang Pharmaceutical Co., Ltd (300267) είναι $0.48835979

Ποια είναι η κεφαλαιοποίηση αγοράς για Hunan Er-Kang Pharmaceutical Co., Ltd (300267)

Η κεφαλαιοποίηση αγοράς για Hunan Er-Kang Pharmaceutical Co., Ltd (300267) είναι $1.01B

Hunan Er-Kang Pharmaceutical Co., Ltd (300267) Τιμή και Κεφαλαιοποίηση Αγοράς

Hunan Er-Kang Pharmaceutical Co., Ltd is a pharmaceutical company that manufactures and sells active pharmaceutical ingredients (APIs), completed drug formulations, and pharmaceutical excipients, serving both the Chinese domestic market and international clients. Its API portfolio features substances such as glycerin, dilute hydrochloric acid, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. The company's principal finished medications include sulbenicillin sodium for injection and compound liquorice tablets. For conventional pharmaceutical excipients, it provides items like pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose. Furthermore, its advanced pharmaceutical excipient offerings encompass hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate along with its related product series. The firm was established in 2003 and is headquartered in Liuyang, China.

Η τιμή για 300267	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$2,552.05 $1.01B	NVDA	$5.264T	+522,475.47%
$2,279.29 $1.01B	AAPL	$4.701T	+466,623.63%
$2,025.20 $1.01B	GOOG	$4.177T	+414,593.29%
$1,850.77 $1.01B	MSFT	$3.817T	+378,876.12%
$1,389.67 $1.01B	AMZN	$2.866T	+284,458.31%

Η τιμή για 300267

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$2,552.05 $1.01B